Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

L-Arginine Treatment for Severe Vascular Fetal Intrauterine Growth Restriction: a Randomized Double Bind Controlled Trial

NCT00549575 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT00549575
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00549575 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
L-Arginine Treatment for Severe Vascular Fetal Intrauterine Growth Restriction: a Randomized Double Bind Controlled Trial
Lead sponsor
Nantes University Hospital
Phase
Phase 3
Overall status
Terminated
Start date
July 31, 2000
Completion date
June 30, 2006
Enrollment
44 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intra uterine growth retardation